GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Baird Medical Investment Holdings Ltd (NAS:BDMD) » Definitions » Net Income Including Noncontrolling Interests

BDMD (Baird Medical Investment Holdings) Net Income Including Noncontrolling Interests : $12.60 Mil (TTM As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Baird Medical Investment Holdings Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Baird Medical Investment Holdings's Net Income Including Noncontrolling Interests for the six months ended in Dec. 2024 was $8.22 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Dec. 2024 was $12.60 Mil.

Baird Medical Investment Holdings Net Income Including Noncontrolling Interests Historical Data

The historical data trend for Baird Medical Investment Holdings's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Baird Medical Investment Holdings Net Income Including Noncontrolling Interests Chart

Baird Medical Investment Holdings Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Net Income Including Noncontrolling Interests
10.18 12.78 10.66 12.60

Baird Medical Investment Holdings Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24 Dec24
Net Income Including Noncontrolling Interests Get a 7-Day Free Trial - 2.36 8.30 4.38 8.22

Baird Medical Investment Holdings Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $12.60 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Baird Medical Investment Holdings Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of Baird Medical Investment Holdings's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.

Baird Medical Investment Holdings Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Baird Medical Investment Holdings Ltd (NAS:BDMD) » Definitions » Net Income Including Noncontrolling Interests
Comparable Companies
CATX INGN QTRX CVRX MASS RCEL SGHT ELMD ARAY LUCD ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM STE PODD
Traded in Other Exchanges
N/A
Address
No.15 Rongtong Street, Room 202, 2nd Floor, Baide Building, Building 11, Yuexiu District, Guangzhou, CHN
Website
Baird Medical Investment Holdings Ltd is one of the microwave ablation medical device developers and providers in the PRC for minimally invasive treatment of tumors. Its proprietary medical devices are used for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps. Microwave ablation is a minimally invasive treatment technique that denaturalizes and coagulates the protein of tumor cells with extreme heat generated by microwave energy. Microwave ablation treatments have been applied to benign and malignant tumors, and the company believes the products are safer, minimally invasive and easier to operate with faster recovery periods and lower complication rates for patients, as compared to traditional treatment methods.